Please use this identifier to cite or link to this item:
http://repo.tma.uz/xmlui/handle/1/3213Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sobirova G.N., Saidrasulova G.B., Abdullaeva U.K., Bafoeva Z.O., Ashirova N.Z., Kurbanaliev X.X., Musakhanov A.K., Gaipov O.U. | - |
| dc.date.accessioned | 2026-04-06T17:44:09Z | - |
| dc.date.available | 2026-04-06T17:44:09Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.issn | 2231-2218 | - |
| dc.identifier.uri | http://repo.tma.uz/xmlui/handle/1/3213 | - |
| dc.description.abstract | Abstract. Osteoarthritis (OA) is a multifactorial, degenerative arthritis. Factors such as obesity, low-grade chronic inflammation, and insulin resistance are key factors in the development and pathogenesis of OA. In summary, OA has been observed to associate with a number of systemic diseases, including obesity, cardiovascular disease, type 2 diabetes, and metabolic syndrome. The importance of non-alcoholic fatty liver disease based on metabolic syndrome is studied in many scientific studies. Recently, scientific work has been carried out to study metabolicassociated fatty liver disease (MAFLD) and related diseases. In this scientific work, the importance of MAFLD in the course of OA is studied. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Asian journal of Pharmaceutical and biological research | en_US |
| dc.subject | osteoarthritis; metabolic syndrome; MASLD; x-ray; VAS scale; | en_US |
| dc.title | SIGNIFICANCE OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE IN OSTEOARTHRITIS | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Articles | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 13. SIGNIFICANCE OF METABOLIC-ASSOCIATED FATTY LIVER.pdf | 393.85 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.